Ma Yanyan, Yu Min, Gao Xuemei
Department of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
J Clin Sleep Med. 2020 Aug 15;16(8):1369-1376. doi: 10.5664/jcsm.8556.
To analyze the effect of gradual increments of mandibular advancement on the treatment efficacy of mandibular advancement devices and identify determinants of effective and target protrusion for OSA.
Patients were prospectively recruited. The mandible was titrated from 0 mm with a stepwise increment of 0.5 mm until the AHI was reduced to the lowest level. Rhinospirometry, rhinomanometry, and magnetic resonance imaging were used to observe the change of respiratory function and upper airway morphology.
Forty-two patients aged 41.5 ± 9.0 years participated. There was a dose-dependent relationship between mandibular protrusion and the AHI improvement rate, the success rate, and the normalization rate; the changing curves plateaued after approximately 70% of maximal mandibular protrusion was achieved. The correlation between AHI and mandibular protrusion became stronger as the severity of OSA increased. The target protrusion for patients with mild, moderate, and severe OSA was 3.5 ± 1.8 mm (38.6 ± 19.4% maximal mandibular protrusion), 5.8 ± 1.9 mm (62.9 ± 18.8% maximal mandibular protrusion), and 5.9 ± 2.2 mm (68.8 ± 15.6% maximal mandibular protrusion), respectively. Regression analysis revealed that the factors influencing effective and target protrusion included change of maximal lateral dimension of the total upper airway with mandibular advancement devices, mean lateral dimension of the oropharynx, and soft palate length. Further protrusion brought more lateral expansion of the velopharynx, whereas the change in nasal ventilation was not significant.
The dose-dependent effect of mandibular protrusion on reduction of AHI by mandibular advancement devices was nonlinear and became more pronounced with increased severity of OSA. The mandibular protrusion should be more personalized to each patient.
Registry: Chinese Clinical Trial Registry; Name: Study of the Onset Point of Oral Appliance Treatment in Obstructive Sleep Apnea and Hypopnea Syndrome; URL: http://www.chictr.org.cn/showproj.aspx?proj=22291; Identifier: ChiCTR-IND-17013232.
分析下颌前伸逐渐增加对下颌前伸装置治疗效果的影响,并确定阻塞性睡眠呼吸暂停(OSA)有效和目标前伸的决定因素。
前瞻性招募患者。下颌从0毫米开始,以0.5毫米的步长递增进行滴定,直到呼吸暂停低通气指数(AHI)降至最低水平。使用鼻气流测定法、鼻阻力测定法和磁共振成像来观察呼吸功能和上气道形态的变化。
42名年龄为41.5±9.0岁的患者参与了研究。下颌前伸与AHI改善率、成功率和正常化率之间存在剂量依赖关系;在下颌最大前伸达到约70%后,变化曲线趋于平稳。随着OSA严重程度的增加,AHI与下颌前伸之间的相关性增强。轻度、中度和重度OSA患者的目标前伸分别为3.5±1.8毫米(下颌最大前伸的38.6±19.4%)、5.8±1.9毫米(下颌最大前伸的62.9±18.8%)和5.9±2.2毫米(下颌最大前伸的68.8±15.6%)。回归分析显示,影响有效和目标前伸的因素包括使用下颌前伸装置时总上气道最大横向尺寸的变化、口咽平均横向尺寸和软腭长度。进一步的前伸使腭咽产生更多的横向扩张,而鼻腔通气的变化不显著。
下颌前伸装置对降低AHI的剂量依赖效应是非线性的,并且随着OSA严重程度的增加而更加明显。下颌前伸应针对每个患者更加个性化。
注册机构:中国临床试验注册中心;名称:阻塞性睡眠呼吸暂停低通气综合征口腔矫治器治疗起始点的研究;网址:http://www.chictr.org.cn/showproj.aspx?proj=22291;标识符:ChiCTR-IND-17013232